-

MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.

What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company’s directors and officers. If you wish to discuss this notice or your legal rights, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

If you have continuously owned MASI shares, you can click or copy and paste the link below in a browser to join: https://www.johnsonfistel.com/investigations/masimo-corporation

What is this about? On or about November 5, 2024, the Court ruled partially granting and partially denying Masimo's motion to dismiss the shareholder class action lawsuit. The Court permitted claims to proceed against Masimo and its Chief Financial Officer, arising from allegations of inflating Sound United's financial performance and misleading investors regarding the integration. Concurrently, the Court dismissed claims against other executive defendants.

About Johnson Fistel, PLLP: Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Colorado, and Idaho. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, PLLP

NASDAQ:MASI
Release Versions
English

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, PLLP

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of DICK’S Sporting Goods, Inc. (DKS)

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of DICK’S Sporting Goods, Inc. (NYSE: DKS) against certain of its officers and directors for alleged breaches of fiduciary duty.What Should DICK’S Shareholders Do?If you have held DICK’S shares continuously since prior to May 25, 2022, you may have standing to seek corporate governance reforms at DICK’S, including improvements to internal controls, transparency, and exe...

CCB Investor Notice: Johnson Fistel Investigates Coastal Financial Corporation Following $68.8 Million Credit Expense

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating Coastal Financial Corporation (NASDAQ: CCB) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. If you purchased Coastal Financial securities and suffered losses, click here to join the investigation. Why Is Johnson Fistel Investigating Coastal Financial? On July 30, 2026, Coastal Financial reported a quarterly net loss of $42.1 million, primarily attributable to $...

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of REGENXBIO Inc. (NASDAQ: RGNX) against certain of its officers and directors for alleged breaches of fiduciary duty. Shareholders who have held REGENXBIO shares continuously since prior to February 9, 2022, may have standing to seek corporate governance reforms, the return of funds to the Company, and a court-approved incentive award, all at no cost to them. What Sho...
Back to Newsroom